Prevalence and Profile of Aspirin Resistance in Hemodialysis Patients
NCT00792272 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2013-07-22
Summary
Dialysis patient could be more aspirin resistant than the general population based on data from chronic kidney disease patients
Conditions
- Aspirin Resistance
Sponsors & Collaborators
-
Staten Island University Hospital
collaborator OTHER -
Northwell Health
lead OTHER
Principal Investigators
-
Suzanne El-Sayegh, MD · SIUH
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-06-30
- Primary Completion
- 2008-11-30
- Completion
- 2008-11-30
More Related Trials
-
Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients
NCT01709994 ·Status: UNKNOWN ·Phase: PHASE3
-
Investigation of Platelet Function and Aspirin Resistance in Chronic Dialysis Patient
NCT01045785 ·Status: UNKNOWN
-
ASPIrin in Reducing Events in Dialysis ( ASPIRED )
NCT04381143 ·Status: RECRUITING ·Phase: PHASE4
-
Aspirin Response in High Risk Patients With Coronary Artery Disease
NCT01383304 ·Status: UNKNOWN
-
Chronic Kidney Disease (CKD) Platelet Study
NCT03649711 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanism Based Resistance to Aspirin
NCT00948987 ·Status: COMPLETED ·Phase: PHASE1
-
Aspirin and the Risk of Microscopic Hematuria in Asymptomatic Screened Population
NCT01615315 ·Status: COMPLETED
-
Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia
NCT01104441 ·Status: COMPLETED
-
Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease
NCT01668901 ·Status: WITHDRAWN ·Phase: PHASE4
-
Aspirin Resistance in Coronary Artery Disease
NCT00753935 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration
NCT00748371 ·Status: TERMINATED ·Phase: PHASE4
-
Genotypic and Phenotypic Correlates of Resistance to Aspirin
NCT01361620 ·Status: COMPLETED ·Phase: NA
-
Aspirin in Reducing Events in the Elderly
NCT01038583 ·Status: UNKNOWN
-
Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients
NCT00427271 ·Status: UNKNOWN ·Phase: PHASE4
-
Duration of Platelet Inhibition by Aspirin
NCT00671021 ·Status: COMPLETED
-
Aspirin Dosing in Diabetic Patients
NCT01201785 ·Status: COMPLETED ·Phase: PHASE4
-
Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients
NCT00129038 ·Status: COMPLETED ·Phase: PHASE4
-
Laboratory Aspirin Resistance in Diabetics and Non-Diabetics
NCT00563875 ·Status: COMPLETED ·Phase: NA
-
Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease
NCT01320072 ·Status: TERMINATED
-
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes
NCT05105919 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Efficacy and Safety Study of Aspirin for the Prevention of Renal Artery Stenosis in Renal Transplantation Recipients
NCT04260828 ·Status: UNKNOWN ·Phase: PHASE4
-
Antiaggregation in Primary Prevention of Vascular Access for Hemodialysis
NCT02055131 ·Status: UNKNOWN ·Phase: PHASE4
-
Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.
NCT00222261 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet Hyperreactivity to Aspirin and Stroke
NCT00766896 ·Status: COMPLETED ·Phase: PHASE4
-
Enteric Coating as a Factor in Aspirin Resistance
NCT00531362 ·Status: COMPLETED